Stoke Therapeutics, Inc. · NASDAQ:STOK

Montrago Trustees Ltd reported a 4.10% stake in Stoke Therapeutics, Inc. (Schedule 13D/A)

Event Aug 22, 2025 · Filed Aug 26, 2025

Montrago Trustees Ltd reported a 4.10% stake in Stoke Therapeutics, Inc., 2,256,181 shares, with active intent on Aug 22, 2025. Filed Aug 26, 2025 (Schedule 13D/A).

Stake
4.10%
Shares
2,256,181
Intent
Active
What changed
Stake changed
Filed together
4 holders

The filing in full

HolderStakeShares
Blue Horizon Enterprise Ltd3.60%1,967,621
Ezbon International Ltd0.50%288,560
Montrago Trustees Ltd4.10%2,256,181
Skorpios Trust4.10%2,256,181

Source

View original at SEC

Related